Personalized Medicine’s Impact on Cancer Care
Video Categories: Personalized MedicineRelated Videos

Explaining Treatment Regimens to Patients with HR+/HER2–Metastatic Breast Cancer
Dr Thomas Bachelot is careful to set reasonable expectations for his patients with HR+/HER2–metastatic breast cancer regarding how long their treatment will last and how it will impact them.
Challenge of Sustainable Pricing Model
Alexander Bastian speaks about the need for a sustainable model of pricing as related to cancer treatments and drug development. He talks about indication-based pricing or tumor-based pricing—says that is compelling, but not necessarily possible in the US.